Skip to main content
. 2019 Nov 8;8(22):e012874. doi: 10.1161/JAHA.119.012874

Table 4.

Incidence Rates of MACE and HEM at 1 Year After PCI (Per 100 Person‐Years)

All Patients (n=919) Black (n=203) White (n=716) IRR (95% CI) P Value
Follow‐up, y 756.9 164.3 592.6
Average follow‐up, y 0.8±0.3 0.8±0.3 0.8±0.3 0.47
Event (n) Rate (%) Event (n) Rate (%) Event (n) Rate (%)
MACE 164 21.7 56 34.1 108 18.2 1.9 (1.3–2.6) <0.001
All‐cause mortality 43 5.7 13 7.9 30 5.1 1.6 (0.8–3.0) 0.19
Nonfatal MI 90 11.9 34 20.7 56 9.4 2.2 (1.4–3.3) <0.001
Nonfatal ischemic stroke 17 2.2 7 4.3 10 1.7 2.5 (0.9–6.7) 0.07
TIA 8 1.1 1 0.6 7 1.2 0.5 (0.02–3.3) 0.60
Stent thrombosis 6 0.8 1 0.6 5 0.8 0.7 (0.03–5.2) 0.84
HEM 90 11.9 29 17.7 61 10.3 1.7 (1.1–2.7) 0.02
Gastrointestinal hemorrhage 42 5.5 18 11.0 24 4.1 2.7 (1.5–5.0) 0.002
Intracranial hemorrhage 5 0.7 0 0 5 0.8 0 (0–3.0) 0.29
Other hemorrhage 43 5.7 11 6.7 32 5.4 1.2 (0.6–2.4) 0.53

For MACE: 11 patients had 2 nonfatal MI events; 2 patients had 2 nonfatal ischemic stroke events; 1 patient had 2 TIA events. For HEM: 16 patients had 2 events and 1 patient had 4 events. HEM indicates major hemorrhage; IRR, incident rate ratio; MACE, major adverse cardiovascular events; MI, myocardial infarction; PCI, percutaneous coronary intervention; TIA, transient ischemic attack.